John P. Mogensen

Novel Tricyclic-α-alkyloxyphenylpropionic Acids:  Dual PPARα/γ Agonists with Hypolipidemic and Antidiabetic Activity

Per Sauerberg, Ingrid Pettersson, Lone Jeppesen et al. · Journal of Medicinal Chemistry · 2002 · 142 citations · Full text

Prediction of PPAR-α ligand-mediated physiological changes using gene expression profiles

Klaus Stensgaard Frederiksen, Erik Max Wulff, Per Sauerberg et al. · Journal of Lipid Research · 2004 · 62 citations · Full text

6-Chloro-3-alkylamino-4<i>H</i>-thieno[3,2<i>-e</i>]-1,2,4-thiadiazine 1,1-Dioxide Derivatives Potently and Selectively Activate ATP Sensitive Potassium Channels of Pancreatic β-Cells

Flemming Nielsen, Thora Bödvarsdóttir, Anne Worsaae et al. · Journal of Medicinal Chemistry · 2002 · 51 citations · Full text

Rat Aorta, Chemical Biology, Experimental Pharmacology +20

Large Dimeric Ligands with Favorable Pharmacokinetic Properties and Peroxisome Proliferator-Activated Receptor Agonist Activity in Vitro and in Vivo

Per Sauerberg, Paul S. Bury, John P. Mogensen et al. · Journal of Medicinal Chemistry · 2003 · 33 citations · Full text

Medicinal Chemistry, Dimeric Ligands, Biochemistry +12

Design and synthesis of novel PPARα/γ/δ triple activators using a known PPARα/γ dual activator as structural template

John P. Mogensen, Lone Jeppesen, Paul S. Bury et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 33 citations · Full text

Biochemistry, Medicine, Drug Discovery +5